Actively Recruiting
Role of Interleukin-13 Pathways on Pain and Itch Sensitivity
Led by Aalborg University · Updated on 2025-06-04
20
Participants Needed
3
Research Sites
103 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Atopic dermatitis (AD) is as chronic, inflammatory skin disorder affecting 20% of the world's population. Intense itch and skin pain are the main symptoms. Research has shown that the proteins interleukins are involved in inflammation and itch in atopic dermatitis. The medicinal product called Lebrikizumab, used for treatment of AD, has shown to block the interleukin called IL-13. The purpose of this experiment is to evaluate the role of IL-13 in itch in both healthy subjects and people with atopic dermatitis.
CONDITIONS
Official Title
Role of Interleukin-13 Pathways on Pain and Itch Sensitivity
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy men and women
- Between 18 and 60 years of age
You will not qualify if you...
- Pregnancy or breastfeeding
- Use of cannabis, opioids, or other drugs indicating drug addiction
- History or current diagnosis of neurological, skin (including atopic dermatitis and psoriasis), immune, muscle, heart, or psychiatric disorders that may affect results
- Presence of moles, wounds, scars, or tattoos in the treatment or test area
- Current use of medications such as antihistamines, painkillers, systemic or topical corticosteroids
- Consumption of alcohol or painkillers within 24 hours before or during study days
- Acute or chronic pain
- Participation in other clinical trials within one week prior to study entry (four weeks for pharmaceutical trials)
- Inability to cooperate with study procedures
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Aalborg University
Gistrup, Aalborg, Denmark, 9260
Actively Recruiting
2
CNAP
Gistrup, Aalborg, Denmark, 9260
Active, Not Recruiting
3
Aalborg University
Aalborg, Denmark, Denmark, 9260
Not Yet Recruiting
Research Team
S
Silvia Lo Vecchio
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here